Nitric oxide in the renal medulla protects from vasopressin-induced hypertension

Hypertension

Volumn 35, Issue 3, 2000, Pages 740-745

  Szentiványi Jr , Mátyás ^a   Park, Frank ^b   Maeda, Celso Y ^b   Cowley Jr , Allen W ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arginine; Arterial pressure; Endothelium; Kidney; Nitric oxide; Nitric oxide synthase; Vasopressins

Indexed keywords

ARGIPRESSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASOPRESSIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; WESTERN BLOTTING;

EID: 4243704027     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.740     Document Type: Article

References (30)

1. Altura BM, Altura BT. Vascular smooth muscle and neurohypophyseal hormones. Fed Proc. 1977;36:1853-1860.
2. Cowley AW Jr. Vasopressin and cardiovascular regulation. In: Guyton AC, Hall JE, eds. Cardiovascular Physiology. IV: International Review of Physiology, Vol 26. Baltimore, Md: University Park Press; 1982.
3. Cowley AW Jr. Role of the renal medulla in volume and arterial pressure regulation. Am J Physiol. 1997;273:R1-R15.
4. Franchini KG, Cowley AW Jr. Sensitivity of the renal medullary circulation to plasma vasopressin. Am J Physiol. 1996;271:R647-R653.
5. Franchini KG, Cowley AW Jr. Renal cortical and medullary blood flow responses during water restriction: role of vasopressin. Am J Physiol. 1996;39:R1257-R1264.
6. Franchini KG, Mattson DL, Cowley AW Jr. Vasopressin modulation of medullary blood flow and pressure-natriuresis-diuresis in the decerebrated rat. Am J Physiol. 1997;272:R1472-R1479.
7. Liard JF, Spadone JC. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs. J Cardiovasc Pharmacol. 1984;6:713-719.
8. Cowley AW Jr, Liard JF. Vasopressin and arterial pressure regulation. Hypertension. 1988;11(suppl I):I-25-I-32.
9. Park F, Zou AP, Cowley AW Jr. Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla. Hypertension. 1998; 32:896-901.
10. 1 arginine vasopressin agonist results in sustained hypertension. Am J Physiol 1994;267: H751-H756.
11. Cowley AW Jr, Skelton MM, Kurth TM. Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial blood pressure. Am J Physiol. 1998;275:R1420-R1424.
12. Zou AP, Cowley AW Jr. Nitric oxide in renal cortex and medulla: an in vivo microdialysis study. Hypertension. 1997;29:194-198.
13. Zou AP, Wu F, Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension. 1998;31:271-276.
14. 2 receptors. Am J Physiol. 1995;269:R193-R200.
15. 2 receptors within the renal cortical and medullary circulation. Am J Physiol. 1997;273:R243-R251.
16. 2 receptor during water restriction. Am J Physiol. 1998; 274:F906-F913.
17. Mattson DL, Nakanishi K, Papanek PE, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 1994;266:H1918-H1926.
18. 1 vasopressin receptors results in sustained hypertension. Am J Physiol. 1994;267:R1241-R1247.
19. Szentiványi M Jr, Maeda CY, Cowley AW Jr. Local renal medullary L-NAME infusion enhances the effect of chronic angiotensin II treatment. Hypertension. 1999;33:440-445.
20. Rudichenko VM, Beierwaltes WH. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J Vasc Res. 1995;32:100-105.
21. Ikenaga H, Fallet RW, Carmines PK. Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANGII in the rat kidney. Am J Physiol. 1996;271:F365-F373.
22. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology. 1992;103:235-239.
23. Mattson DL, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension. 1996;27:688-692.
24. Moridani BA, Kline RL. Effect of endogenous L-arginine on the measurement of nitric oxide synthase activity in the rat kidney. Can J Physiol Pharmacol. 1996;74:1210-1214.
25. Wu F, Park F, Cowley AW Jr, Mattson DL. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am J Physiol. 1999;276:F271-F278.
26. Hennington BS, Zhang H, Miller MT, Granger JP, Reckelhoff JF. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension. 1998;31:283-288.
27. Kone BC. Localization of nitric oxide synthase isoforms in the kidney. Semin Nephrol. 1999;19:230-241.
28. Pawloski CM, Eicker NM, Ball LM, Mangiapane ML, Fink GD. Effect of circulating vasopressin on arterial pressure regulation in rats. Am J Physiol. 1989;257:H209-H218.
29. Cowley AW Jr, Monos E, Guyton AC. Interaction of vasopressin and the baroreceptor system in the regulation of arterial blood pressure in the dog. Circ Res. 1974;34:505-514.
30. Leaf A, Bartter FC, Santos RF, Wrong O. Evidence that urinary electrolyte loss induced by pitressin is a function of water retention. J Clin Invest. 1953;32:868-878.